Published: January 8, 2026 at 8:51 am
MedPal AI has launched what it believes to be a UK-first direct integration between a consumer health app and a regulated pharmacy, using AI to guide users into personalised, clinically supervised treatment pathways.
The AIM-listed digital health company’s app now uses AI to analyse aggregated user health data, including BMI, to identify individuals who may benefit from weight management support, GLP-1 treatments or other clinically prescribed medicines available through its online MedPal Clinic.
The system only directs users into clinical assessment pathways if they meet eligibility criteria, a move the company says ensures responsible targeting rather than broad advertising of weight loss drugs.